These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 22977660)

  • 21. Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways.
    Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
    Virchows Arch; 2009 Nov; 455(5):413-22. PubMed ID: 19855998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Malignant transformation of ovarian endometriosis: a clinicopathologic analysis of 49 cases].
    Shen YM; Wu XL; Xu L; Huang Q; Yu N; Yao XY; Xie YP
    Ai Zheng; 2008 Oct; 27(10):1106-10. PubMed ID: 18851793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
    Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preneoplasias of ovarian carcinoma: biological and clinical aspects of different pathways of tumorigenesis].
    Staebler A
    Pathologe; 2011 Nov; 32 Suppl 2():265-70. PubMed ID: 21809064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression.
    Kato N; Motoyama T
    Histopathology; 2008 May; 52(6):682-8. PubMed ID: 18393978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ovarian clear cell borderline tumour: a clinicopathologic analysis].
    Gu WY; Zhang LL; Zhang H; Pan QZ; Qu YQ; Tao X; Ning Y
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):622-626. PubMed ID: 30107668
    [No Abstract]   [Full Text] [Related]  

  • 27. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
    Mandai M; Yamaguchi K; Matsumura N; Baba T; Konishi I
    Int J Clin Oncol; 2009 Oct; 14(5):383-91. PubMed ID: 19856044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas.
    Wiegand KC; Lee AF; Al-Agha OM; Chow C; Kalloger SE; Scott DW; Steidl C; Wiseman SM; Gascoyne RD; Gilks B; Huntsman DG
    J Pathol; 2011 Jul; 224(3):328-33. PubMed ID: 21590771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma.
    Fujimura M; Hidaka T; Kataoka K; Yamakawa Y; Akada S; Teranishi A; Saito S
    Am J Surg Pathol; 2001 May; 25(5):667-72. PubMed ID: 11342781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma.
    Ayhan A; Mao TL; Seckin T; Wu CH; Guan B; Ogawa H; Futagami M; Mizukami H; Yokoyama Y; Kurman RJ; Shih IeM
    Int J Gynecol Cancer; 2012 Oct; 22(8):1310-5. PubMed ID: 22976498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathology of clear cell carcinoma of the ovary: A basic view based on cultured cells and modern view from comprehensive approaches.
    Kato N
    Pathol Int; 2020 Sep; 70(9):591-601. PubMed ID: 32476214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis.
    Yachida N; Yoshihara K; Suda K; Nakaoka H; Ueda H; Sugino K; Yamaguchi M; Mori Y; Yamawaki K; Tamura R; Ishiguro T; Isobe M; Motoyama T; Inoue I; Enomoto T
    Sci Rep; 2020 Aug; 10(1):14260. PubMed ID: 32868822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
    Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
    [No Abstract]   [Full Text] [Related]  

  • 34. Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.
    Abou-Taleb H; Yamaguchi K; Matsumura N; Murakami R; Nakai H; Higasa K; Amano Y; Abiko K; Yoshioka Y; Hamanishi J; Koshiyama M; Baba T; Yamada R; Matsuda F; Konishi I; Mandai M
    Oncotarget; 2016 Aug; 7(34):54758-54770. PubMed ID: 27340867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary.
    Kobayashi H; Yamada Y; Kanayama S; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
    Int J Gynecol Cancer; 2009 Apr; 19(3):471-9. PubMed ID: 19407577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium.
    Fadare O; Gwin K; Desouki MM; Crispens MA; Jones HW; Khabele D; Liang SX; Zheng W; Mohammed K; Hecht JL; Parkash V
    Mod Pathol; 2013 Aug; 26(8):1101-10. PubMed ID: 23524907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.
    Yamamoto S; Tsuda H; Takano M; Tamai S; Matsubara O
    Mod Pathol; 2012 Apr; 25(4):615-24. PubMed ID: 22157930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in β-catenin, microsatellite instability, and HNF-1β levels are independently associated with ovarian endometriosis-associated tumorigenesis.
    Tomohiro M; Matsumoto T; Miura R; Oguri Y; Yokoi A; Tochimoto M; Saegusa M
    Hum Pathol; 2019 Jul; 89():10-23. PubMed ID: 31022415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis.
    Ayhan A; Kuhn E; Wu RC; Ogawa H; Bahadirli-Talbott A; Mao TL; Sugimura H; Shih IM; Wang TL
    Mod Pathol; 2017 Feb; 30(2):297-303. PubMed ID: 27767100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
    Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
    J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.